Escozine Hp
FDA Label NDC 70891-201

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medolife Corporation for the product Escozine Hp (NDC 70891-201). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients:, warnings:, directions:, inactive ingredients:, keep out of reach of children:, indications:, questions:, purpose:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label Display:

Principal display panel

Box (Escozine Hp Box)

Box (Escozine Hp Box)

Label (Escozine Hp Label)

Label (Escozine Hp Label)

* Please review the disclaimer below.